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Studies have shown short-term effects of
particulate pollution (PM) on hospital admis-
sions and deaths from cardiovascular causes
(Anderson et al. 2003; Braga et al. 2001;
Dockery 2001; Katsouyanni et al. 1996; Pope
et al. 2004a; Samet et al. 2000; Schwartz
1999; Zanobetti et al. 2000). Myocardial
infarctions (MIs) have been shown to be sus-
ceptible to being triggered by PM (Braga
et al. 2001; D’Ippoliti et al. 2003; Lanki et al.
2006; Peters et al. 2001a; von Klot et al.
2005; Zanobetti and Schwartz 2005). These
studies have not addressed whether persons
who survive an MI are at risk of death in
response to subsequent particle exposure.
A few studies have addressed this question
with respect to acute exposure. For example,
Bateson and Schwartz (2004) reported sub-
jects in Chicago who were discharged alive
for an MI had twice the risk of death due to
acute air pollution exposure as other subjects. 
In a recent study of ﬁve European cities,
von Klot et al. (2005) found that ambient air
pollution was associated with increased risk of
hospital cardiac readmissions of MI survivors.
Peters et al. (2006) examined the probability
of recurrent hospitalization in a cohort of MI
survivors; compared the use of time-series,
case–crossover, and survival analysis for ana-
lyzing short-term health effects; and found
that the three methods gave similar results.
None of these studies examined the effect of
longer-term exposure on survival. 
Several studies have examined the effect
of longer-term PM exposure on survival in
general cohorts. The Harvard Six Cities Study
(Dockery et al. 1993) demonstrated an associ-
ation between mortality and chronic exposure
to PM. A recent reanalysis of the Harvard Six
Cities Study, which extended the mortality
follow-up period, used a similar approach to
our study and included PM2.5 (PM with aero-
dynamic diameter < 2.5 µm) as a time-varying
exposure; Laden et al. (2006) found signifi-
cant association of PM2.5 with mortality.
Two articles (Pope et al. 2002, 2004a)
have shown an association between PM and
mortality in the American Cancer Society
(ACS) Cancer Prevention Study population,
including an association between PM and
deaths from all cardiovascular disease (Pope
et al. 2004a). 
These studies have treated air pollution as
a city-level variable, whereas two European
cohort studies have assessed exposure at an
individual level. Hoek et al. (2002) found an
association between estimated long-term
exposure to traffic-related particles at each
participant’s home and cause-speciﬁc mortal-
ity in the Netherlands Cohort Study on Diet
and Cancer. Nafstad et al. (2004) found an
association between estimated nitrogen diox-
ide concentrations at the subject’s home and
the risk of dying for total, respiratory, lung
cancer, and ischemic heart disease mortality
in a cohort of men in Oslo, Norway. Particle
data was not available in that study, and NO2
was used as a marker of trafﬁc pollution. 
Although these studies have reported an
association of PM with survival, they have
not evaluated the role of preexisting cardiac
disease or whether risk changed with annual
changes in exposure, nor have they treated
pollution as a time-varying covariate. 
Reduced heart rate variability has been
associated with decreased survival of MI
patients (Ewing 1991; Malik et al. 1989), and
PM has been associated with reduced heart
rate variability (Creason et al. 2001; Gold et al.
2000; Liao et al. 1999; Park et al. 2005; Pope
et al. 1999), which in turn is associated with
decreased post-MI survival (Stein et al. 2005).
Other studies have suggested that PM may be
associated with increased C-reactive protein
(Brook et al. 2003; Peters et al. 2001b), which
is associated with mortality risk following an
MI (Kinjo et al. 2005). PM and its compo-
nents have also been shown to increase oxida-
tive stress in the heart (Bouthillier et al. 1998;
Brook et al. 2003; Dhalla et al. 2000; Sorensen
et al. 2003), to decrease plaque stability (Suwa
et al. 2002), and to increase atherosclerosis
(Künzli et al. 2005). Based on this, we investi-
gated whether annual PM exposure was associ-
ated with progression of disease or reduced
survival in a study of 196,000 persons dis-
charged alive following an acute MI.
Materials and Methods
Study population. Using Medicare data for
persons ≥ 65 years of age, we constructed a
cohort of survivors of acute MI, deﬁning cases
as emergency admissions for a primary dis-
charge diagnosis of MI [International
Classification of Diseases, Ninth Revision
(ICD-9; World Health Organization 1975)
code 410] discharged alive between 1985 and
1999 in any of 21 cities chosen to represent a
broad range of the country. We obtained from
Medicare the date of death for each subject, or
whether they were still alive as of the end of
1999. We also retrieved information on age,
sex, race, and the number of coronary inten-
sive care days and Medical intensive care days. 
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OBJECTIVE: Several studies have examined the effect of particulate pollution (PM) on survival in
general populations, but less is known about susceptible groups. Moreover, previous cohort studies
have been cross-sectional and subject to confounding by uncontrolled differences between cities. 
DESIGN: We investigated whether PM was associated with progression of disease or reduced survival
in a study of 196,000 persons from 21 U.S. cities discharged alive following an acute myocardial
infarction (MI), using within-city between-year exposure to PM. We constructed city-specific
cohorts of survivors of acute MI using Medicare data between 1985 and 1999, and deﬁned three
outcomes on follow-up: death, subsequent MI, and a first admission for congestive heart failure
(CHF). Yearly averages of PM10 (particulate matter with aerodynamic diameter < 10 µm) were
merged to the individual annual follow-up in each city. We applied Cox’s proportional hazard
regression model in each city, with adjustment for individual risk factors. In the second stage of the
analysis, the city-speciﬁc results were combined using a meta-regression.
RESULTS: We found signiﬁcant associations with a hazard ratio for the sum of the distributed lags of
1.3 [95% conﬁdence interval (CI), 1.2–1.5] for mortality, a hazard ratio of 1.4 (95% CI, 1.2–1.7)
for a hospitalization for CHF, and a hazard ratio of 1.4 (95% CI, 1.1–1.8) for a new hospitalization
for MI per 10 µg/m3 PM10.
CONCLUSIONS: This is the ﬁrst long-term study showing a signiﬁcant association between particle
exposure and adverse post-MI outcomes in persons who survived an MI.
KEY WORDS: air pollution, epidemiology, heart diseases, myocardial infarction, survival. Environ
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20 February 2007]To study progression of disease, we traced
each subject through subsequent Medicare
records and identified admissions for a sub-
sequent MI or for congestive heart failure
(CHF; ICD-9 code 428).
Subjects alive the first of January of the
year following the admission were entered into
the cohort, and follow-up periods were calen-
dar years. We excluded subjects whose death
or subsequent admission occurred within the
ﬁrst 3 months of their index admission. 
We also used a unique identiﬁer for each
subject to assess medical factors that might
modify the risk of survival or progression, such
as whether they had any primary or secondary
diagnosis of chronic obstructive pulmonary
disease (COPD; ICD-9 codes 490–496,
except 493), diabetes (ICD-9 code 250), or
essential hypertension (ICD-9 code 401); or if
they had previous admissions for atrial ﬁbrilla-
tion (ICD-9 code 427.3). 
During 1985–1999 changes in treatment
occurred, such as introduction of thrombolyt-
ics and increased angioplasty. To control for
changes in postdischarge survival, we used
strata to allow a different underling hazard for
each 5-year interval in the study. 
We deﬁned a categorical variable for type
of MI as given by the fourth digit of the
ICD-9 code. There are 10 different types of
MI: ICD-9 code 410.0, MI of anterolateral
wall; 410.1, other anterior wall; 410.2, infero-
lateral wall; 410.3, inferoposterior wall; 410.4,
other inferior wall; 410.5, other lateral wall;
410.6, true posterior wall infarction; 410.7,
subendocardial infarction; 410.8, other speci-
ﬁed sites; and 410.9, unspeciﬁed sites. 
City characteristics, such as population
density and percentage of population
≥ 65 years of age in poverty status, were
obtained from the 1990 U.S. census (U.S.
Census Bureau 2000). The average annual
mortality rate for emphysema among people
≥ 65 years of age during 1989–2000 were
obtained from the National Center for
Health Statistics (Hyattsville, MD) and used
as an indirect measure of smoking history in
each city. 
The accuracy of the Medicare claims-based
diagnosis of MI has been recently validated
(Kiyota et al. 2004). 
Environmental data. We obtained data
for PM10 (particulate air matter with aero-
dynamic diameter < 10 µm) for 1985–1999
from the U.S. Environmental Protection
Agency’s Aerometric Information Retrieval
System (Nehls and Akland 1973). 
We selected the following cities with daily
PM10 monitoring that represent a geographic
distribution across the country: Birmingham,
Alabama; Boulder, Colorado; Canton, Ohio;
Chicago, Illinois; Cincinnati, Ohio; Cleveland,
Ohio; Colorado Springs, Colorado; Columbus,
Ohio; Denver, Colorado; Detroit, Michigan;
Honolulu, Hawaii; Houston, Texas;
Minneapolis-St.Paul, Minnesota; Nashville,
Tennessee; New Haven, Connecticut;
Pittsburgh, Pennsylvania; Provo-Orem, Utah;
Salt Lake City, Utah; Seattle, Washington;
Steubenville, Ohio; and Youngstown, Ohio. 
For most cities, the metropolitan county
encompassed the city and much of its suburbs,
but we used multiple counties for Minneapolis-
St. Paul (Ramsey and Hennepin), Birmingham
(Blount, Jefferson, St. Clair, Shelby, and
Walker), Steubenville (Jefferson, OH; Brooke
and Hancock, WV), and Youngstown
(Columbiana and Mahoning). 
For each subject and follow-up period we
created yearly averages (January–December)
of pollution for that year and lags up to the
3 previous years.
Analytical strategy. We deﬁned the cohort
as follows: We assumed that a subject admit-
ted for MI enters the cohort if he survived at
least 3 months and/or is alive the ﬁrst January
of the year following the admission. For each
subject, the follow-up periods were 1 year
periods (January–December) until the year in
which they die (or suffer a subsequent MI or
CHF admission for those analyses) or until
December 1999 (censoring). 
City-speciﬁc cohorts were created for the
three survival analyses, one where failure was
defined as death, one where failure was
defined as a new MI, and one where failure
was deﬁned as a ﬁrst admission for CHF.
We analyzed the data with an extended
Cox’s proportional hazard regression model,
which allows for time-varying covariates in
survival analysis (Kleinbaum and Klein 2005).
The model for the hazard h at time t is
h[t,X(t)] = 
h0(t) exp[Σi =1to p1 βi Xi + Σj=1 to p2 δj Zj(t)], [1]
where t is time since a subject entered the
cohort (January) after the admission for MI
and is represented by 1 year; X1,…Xp1 are
time-invariant variables such as sex; and Z1(t),
…, Zp2(t) are time-varying variables such as
air pollution. 
We adjusted for individual risk factors
including age, sex, race, type of MI, number
of days of coronary care and intensive care,
previous diagnoses for atrial fibrillation, and
secondary or previous diagnoses for COPD,
diabetes, and hypertension, and for season of
initial event as cold (December–February),
hot (June–August), and transitional. To allow
for possible nonproportionality of the sur-
vival rates, time period (three categories:
1985–1989, 1990–1994, and 1995–1999),
age (5-year categories), sex, race (white, black,
others), and type of MI (10 categories) were
treated as stratiﬁcation variables. 
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Table 1. Characteristics of the study population among residents of 21 U.S. cities.
Mean 
Characteristic No. of events Percent (5th–95th percentiles)
MI 196,131
Failure
Deaths 89,249 45.5
CHF 33,764 17.2
Subsequent MI 22,552 11.5
Baseline characteristics
Age 76.1 (66.5–89.1)
Sex 
Male 98,822 50.4
Female 97,309 49.6
Race
White 165,549 84.4
Black 19,759 10.1
Other 10,823 5.5
No. of days in coronary care 1.3 (0–6.5)
No. of days in intensive care 1.5 (0–6.5)
Type of MI
Anterolateral wall 10,088 5.1
Other anterior wall 37,993 19.4
Inferolateral wall 6,434 3.3
Inferoposterior wall 4,291 2.2
Other inferior wall 44,923 22.9
Other lateral wall 5,326 2.7
True posterior wall infarction 2,009 1.0
Subendocardial infarction 66,628 34.0
Other speciﬁed sites 3,951 2.0
Unspeciﬁed sites 14,488 7.4
Secondary or previous diagnoses
COPD 28,509 14.5
Diabetes 44,686 22.8
Hypertension 72,154 36.8
Previous admissions
Atrial ﬁbrillation 11,374 5.8Ties were treated using the approach of
Kalbﬂeisch and Prentice (1980). 
As a sensitivity analysis, we considered an
alternative deﬁnition of our follow-up period.
We defined yearly follow-up (and exposure
averages) using a 12-month period starting
the month of their index admission. We con-
tinued to construct 12-month average PM
exposure for each subject for each subsequent
year of follow-up (using month of initial
event as the anniversary) until censoring
or failure. In the last follow-up period for
each subject, the person time at risk was
< 12 months, and this was incorporated in
the model. However, PM exposure was kept
as a 12-month average to maintain compara-
bility with other periods. When the last fol-
low-up period was ≤ 3 months, subjects were
censored at their last complete 12-month
period of follow-up because the exposure
interval was judged too short to be compara-
ble to the 12-month exposure used for the
follow-up periods. 
We also restricted the mortality and CHF
cohorts to subjects with a second MI, with
follow-up beginning after the occurrence of
their second MI, or including only those sub-
jects who were admitted for their primary MI
between 1985 and 1996, allowing at least
3 years of follow-up to all subjects in the
analysis. 
For each subject in each follow-up period,
we considered the following possible exposure
indexes: a) the average PM10 in their city in
that follow-up period; and b) a model con-
taining simultaneously the exposure during
the follow-up period and each of the three
previous years (distributed lag), to see if we
could determine how the PM dropped off
over time. 
We ﬁrst performed city-speciﬁc analyses;
in the second stage of the analysis, the results
were combined using the meta-regression
technique of Berkey et al. (1998). To be con-
servative, we report the results incorporating a
random effect, whether or not there was a sig-
niﬁcant heterogeneity. 
Effect modiﬁcation by individual risk fac-
tors was examined by ﬁtting separate propor-
tionate hazard models for each group (e.g.,
sex) in each city, controlling for covariates and
combining across cities as in the main analysis.
In addition, we examined effect modiﬁcation
by city characteristics by entering them as pre-
dictor variables in the meta-regression. These
included measures of socioeconomic condition
(percent in poverty), exposure-related meas-
ures (mean and interquartile range of PM10 in
the city), general social factors (population
density), and the emphysema death rate in
persons ≥ 65 years of age as a surrogate for the
smoking history of the population. The
results are expressed as hazard ratio (HR) for
10 µg/m3 PM10. 
Results 
There were 196,131 eligible MIs in the
21 cities during the study period. Table 1
shows characteristics of the study population
for all the cities. Of the population, 45.5%
died by the end of follow-up, 17% had a
CHF admission after the index MI, and
11.5% had a subsequent MI. In the cohort,
63% of the subjects were ≥ 75 years of age.
The most common types of MI were sub-
endocardial infarction (34%), MI of other
inferior wall (23%), and MI of other anterior
wall (19%). 
The average duration of the follow-up was
5.1 years for mortality, 3.7 years for CHF,
and 3.6 years for subsequent MI. The range
of survival times in all the cohorts varied from
1 to 14 years. 
Table 2 presents city-speciﬁc characteris-
tics, including the total population, PM con-
centrations, counts of hospital admissions
for MI, and the numbers of deaths, subse-
quent acute MI, and ﬁrst hospitalizations for
CHF. The average PM10 across all cities was
28.8 µg/m3. 
Table 3 presents the city-speciﬁc incidence
rates for the three outcomes. In total, the inci-
dence rates were 0.091 for death, 0.054 for
CHF admission, and 0.027 for subsequent
MI. The incidence rates among all cities were
examined by year (Table 4); these were higher
in the first 5 years but changed little during
Air pollution and MI survival
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Table 3. Accrued person-time and incidence rate for the three survival analyses.
Person-years Incidence rate
City Deaths CHF 2nd MI Deaths CHF 2nd MI
Birmingham, AL 44,672 28,995 39,495 0.120 0.063 0.026
Boulder, CO 6,292 4,014 5,305 0.084 0.044 0.018
Canton, OH 23,826 15,333 20,336 0.108 0.052 0.029
Chicago, IL 207,151 125,216 180,216 0.123 0.061 0.028
Cincinnati, OH 39,967 25,530 35,255 0.118 0.054 0.026
Cleveland, OH 83,790 52,392 72,310 0.116 0.060 0.026
Colorado Springs, CO 10,475 7,813 9,430 0.080 0.036 0.018
Columbus, OH 37,725 24,977 33,535 0.120 0.055 0.031
Denver, CO 22,424 15,187 20,178 0.084 0.036 0.018
Detroit, MI 87,612 55,024 74,111 0.123 0.063 0.028
Honolulu, HI 21,831 14,842 19,632 0.113 0.043 0.025
Houston, TX 52,910 36,734 46,250 0.113 0.049 0.021
Minneapolis, MN 51,318 34,124 46,421 0.096 0.040 0.022
Nashville, TN 20,710 14,039 18,168 0.113 0.050 0.025
New Haven, CT 46,935 28,516 40,926 0.113 0.051 0.027
Pittsburg, PA 101,145 63,399 82,726 0.124 0.058 0.034
Provo/Orem, UT 8,138 5,401 6,798 0.081 0.048 0.020
Salt Lake City, UT 19,021 13,236 17,136 0.080 0.032 0.015
Seattle, WA 52,168 34,519 46,465 0.094 0.038 0.020
Steubenville, OH 11,674 6,986 9,311 0.123 0.071 0.032
Youngstown, OH 27,146 16,902 23,182 0.120 0.061 0.033
Total 976,930 623,179 847,186 0.091 0.054 0.027
Table 2. City-speciﬁc counts of hospital admissions for MI, second MI, ﬁrst CHF, and deaths and for distri-
bution of PM10.
MI CHF 2nd MI No. ≥ 65 PM10
a (%)
City admissions Deaths events events years of ageb 10 50 90
Birmingham, AL 8,927 4,281 1,814 1,028 120 22.8 27.0 38.2
Boulder, CO 1,117 434 176 97 17 18.0 20.6 28.9
Canton, OH 4,788 2,061 797 594 53 22.1 25.2 28.4
Chicago, IL 42,091 20,333 7,673 5,130 632 29.5 33.4 38.5
Cincinnati, OH 7,961 3,778 1,381 906 115 25.5 30.7 38.2
Cleveland, OH 16,648 7,767 3,140 1,899 221 35.2 37.6 42.5
Colorado Springs, CO 2,054 672 282 173 32 18.4 21.0 24.9
Columbus, OH 7,859 3,574 1,370 1,044 92 25.6 28.5 31.6
Denver, CO 3,919 1,551 546 357 64 26.6 28.9 36.5
Detroit, MI 18,437 8,490 3,439 2,098 264 28.0 31.3 37.9
Honolulu, HI 4,528 1,952 633 484 91 14.8 16.3 18.7
Houston, TX 10,885 4,764 1,812 975 196 26.0 29.7 32.3
Minneapolis, MN 10,123 3,962 1,360 1,019 176 22.3 24.7 31.8
Nashville, TN 4,081 1,877 697 449 59 27.1 30.2 38.5
New Haven, CT 9,232 4,245 1,447 1,119 118 22.2 24.0 29.3
Pittsburg, PA 20,663 10,007 3,653 2,800 233 25.2 29.5 34.3
Provo/Orem, UT 1,504 535 258 136 18 26.3 32.4 38.5
Salt Lake City, UT 3,535 1,233 425 256 61 28.2 34.1 43.3
Seattle, WA 9,674 4,011 1,325 921 167 16.0 22.6 31.7
Steubenville, OH 2,502 1,130 499 302 24 26.4 33.9 37.7
Youngstown, OH 5,603 2,592 1,037 765 61 27.2 29.2 33.3
aDistribution of the individually assigned 1-year PM10 mean in each city. bPopulation ≥ 65 years of age (× 1,000).the following years, justifying the use of three
categories to describe the time period. 
We found significant associations in the
three survival analyses adjusting for con-
founders (Table 5), with a hazard ratio for the
sum of the distributed lag for mortality of 1.3
[95% confidence interval (CI), 1.2–1.5] per
10 µg/m3 PM10, a hazard ratio of 1.4 (95%
CI, 1.2–1.7) for CHF, and a hazard ratio of
1.4 (95% CI, 1.1–1.8) per 10 µg/m3 PM10
for a new hospitalization for MI. The distrib-
uted lag model shows greater effects at lags 1
and 2 exposure, with an overall effect consid-
erably larger than for a single year. 
Table 6 presents the results of the sensitiv-
ity analyses. When we restricted the mortality
and CHF analysis to subjects with a second
MI with follow-up beginning after the occur-
rence of their second MI, the effect of PM10
for the distributed lag model showed an
HR of 1.3 (95% CI, 1.15–1.55) in the mor-
tality cohort and an HR of 1.4 (95% CI,
1.22–1.65) in the CHF cohort. Including
only those subjects who were admitted for
their primary MI between 1985 and 1996,
that is, with at least 3 years of follow-up, we
found higher estimates than the main results
reported in Table 5.
In Table 6 we also present the result of
the sensitivity analysis in which we modiﬁed
the definition of the cohort. For the distrib-
uted lag, we found an HR for mortality of 1.3
(95% CI, 1.15–1.4) per 10 µg/m3 PM10; this
HR is similar to the main result in Table 5.
Figure 1 shows the results of the analysis
of effect modiﬁcation by sex and age groups
(65–75 years of age and ≥ 76 years). We did
not find effect modification by sex, but we
did find a higher effect in the older age
group. Following the method of Payton et al.
(2003) to determine whether the difference
between the age groups was significant, we
found a p-value for mortality of 0.064,
whereas the p-value for subsequent MI and
CHF was 0.082. 
We used meta-regression (Berkey et al.
1998) to examine predictors of heterogeneity
across city (Table 7), and we found that most
of the predictors were not signiﬁcant as modi-
ﬁers of the PM10 effect. 
Discussion
We found a significant effect of long-term
exposure to airborne particles on the risk of
death, progression to heart failure, and a subse-
quent MI in a large multicity study of subjects
discharged alive following an acute MI. This
association was not due to differences between
cities in exposure, but resulted from the associ-
ation of year-to-year changes in mortality risk
with year-to-year changes in exposure. We
found that association persisted for several
years of lag, but was falling off by lag 3. 
Although several previous studies have
reported an association of PM with mortality
in survival analysis, this is the ﬁrst long-term
study that investigated persons discharged
alive following an acute MI and showed that
persons who survive an MI are at risk of death
in response to subsequent particle exposure.
The present study is the first large cohort
study focused on the elderly.
One key difference between the present
study and previous cohorts comes from the
source of variation in exposure. In the other
cohort studies, the source of exposure varia-
tion is across geographic area. For example,
the ACS study (Pope et al. 2004a) contrasted
covariate-adjusted survival in each city with
long-term average pollution in that city.
Using such an approach, unmeasured factors
that vary across city are potential con-
founders. For example, substantial geographic
variability in the use of cardiovascular medi-
cation has been reported in a number of stud-
ies, and this was not controlled in previous
cohort studies. In the present study the basic
analysis was conducted within each city, and
exposure variation comes from temporal
changes in pollution concentration. This
eliminates those potential confounders as a
concern. By focusing on 12-month average
exposures, it also eliminates the potential con-
founding by short-term weather factors that
are an issue in time-series studies. Obviously,
factors that ﬂuctuate from year to year within
each city are potential confounders in this
study design. The advantage of this approach
is that it allows us to use an analytical
methodology with different vulnerabilities to
confounding than in previous studies; to
determine whether an association between
PM and mortality risk persists; and to exam-
ine an intermediate time period of expo-
sure—in contrast to the use of daily exposure
in time-series studies—and exposure over
many years in other cohorts. 
The use of longitudinal rather than cross-
sectional exposure gradients in this study may
also explain some of the differences in effect
size estimates, because the variation in central
station monitoring and personal exposure over
time may be more correlated than similar vari-
ations over space. Moreover, the ACS study
Zanobetti and Schwartz
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Table 4. Accrued person-years, number of deaths,
and incidence rate (IR) across all cities by year for
the mortality cohort.
Year Person-years No. of deaths IR
1986 10,015 1,423 0.142
1987 22,094 2,808 0.127
1988 32,640 3,675 0.113
1989 41,852 4,173 0.100
1990 50,173 4,786 0.095
1991 59,419 5,581 0.094
1992 67,713 6,223 0.092
1993 76,769 6,711 0.087
1994 85,574 7,709 0.090
1995 93,209 8,427 0.090
1996 100,260 8,803 0.088
1997 107,150 9,152 0.085
1998 113,019 9,617 0.085
1999 117,043 10,161 0.087
Table 5. HR and 95% CI for 10-µg/m3 increase in
PM10 for the year of failure and for the distributed
lag from the year of failure up to 3 previous years.
Failure HR 95% CI p-Values
Death
PM10 annual 1.11 1.05–1.19 0.001
Distributed lag model
Lag 0 1.04 0.96–1.14 0.336
Lag 1 1.07 0.99–1.14 0.070
Lag 2 1.14 1.10–1.18 0.000
Lag 3 1.06 0.99–1.12 0.077
Sum lags 0–3 1.34 1.17–1.52 0.000
CHF
PM10 annual 1.11 1.03–1.21 0.009
Distributed lag model
Lag 0 1.09 1.01–1.18 0.030
Lag 1 1.09 1.01–1.19 0.038
Lag 2 1.13 1.02–1.25 0.014
Lag 3 1.04 0.97–1.12 0.260
Sum lags 0–3 1.41 1.19–1.66 0.000
Second MI
PM10 annual 1.17 1.05–1.31 0.003
Distributed lag model
Lag 0 1.09 0.92–1.30 0.325
Lag 1 1.12 0.97–1.30 0.108
Lag 2 1.15 1.08–1.23 0.000
Lag 3 1.01 0.94–1.09 0.783
Sum lags 0–3 1.43 1.12–1.82 0.005
Models controlled for season, days of coronary care and
intensive care, previous diagnosis for atrial ﬁbrillation, and
secondary or previous diagnoses for COPD, diabetes, and
hypertension; we adjusted for time period, age, sex, race,
and type of MI as stratiﬁcation variables. 
Table 6. HR and 95% CI for 10 µg/m3 increase in PM10 (sum of previous 3 years distributed lag) for the sen-
sitivity analyses.
HR 95% CI p-Values
Death
Subjects with subsequent MIa 1.33 1.15–1.55 0.000
Subjects admitted between 1985 and 1996b 1.45 1.26–1.68 0.000
Second deﬁnition of cohortc 1.29 1.15–1.44 0.000
CHF
Subjects with subsequent MIa 1.42 1.22–1.65 0.000
Subjects admitted between 1985 and 1996b 1.51 1.26–1.81 0.000
Subsequent MI
Subjects admitted between 1985 and 1996b 1.62 1.23–2.13 0.001
aFollow-up started after subsequent MI. bIncludes only primary admission for MI during 1985 and 1996. cYearly follow-up
and 12-month average PM10 exposure for each subject for each subsequent year of follow-up starting from the month of
the index admission until censoring or failure.Air pollution and MI survival
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(Pope et al. 2004a) used monitors within the
multicounty metropolitan areas to assign expo-
sure, whereas our subjects are matched to mon-
itors in the same city or county. A recent
reanalysis of ACS data restricting to persons
living in the same county of the monitor
reported a larger risk (Pope et al. 2004a; Willis
et al. 2003). 
The sensitivity analysis in the present
study showed that subjects with a second MI
have a higher risk of a PM-associated subse-
quent death. Hence, this appears to represent
a particularly susceptible group. 
In a recent case–crossover study examining
this association, Bateson and Schwartz (2004)
reported much smaller relative risks (1.02; 95%
CI, 0.99–1.04). In another case–crossover
study (Zanobetti and Schwartz 2005) on 21
U.S. cities, we analyzed the short-term effect of
PM10 on the MI hospitalization in these cities.
In that analysis, we also found a smaller relative
risk (1.007; 95% CI, 1.003–1.01). Although
part of the association reported here may be
acute, the evidence indicates cumulative expo-
sure over a year or more elevates risk above and
beyond the effects of acute exposure. 
We observed a high degree of heterogene-
ity among the cities. In multicities time-series
studies of short-term effect of air pollution on
health, heterogeneity has been found among
cities (Katsouyanni et al. 2001; Le Tertre et al.
2002; Samet et al. 2000). Heterogeneity has
been attributed to, for example, differences in
particle characteristics, ventilation rates of
buildings, average PM10 concentrations, and
social conditions. Previously published cohort
studies could not address the issue of hetero-
geneity because the studies were essentially
cross-sectional; the source of exposure variation
was across geographic area. This is the first
long-term study to show significant hetero-
geneity among cities in response to long-term
exposure, and the cause of this heterogeneity
needs to be determined. 
This analysis advances the field a)b y
reporting an association between particle expo-
sure and survival in a cohort study of MI sur-
vivors that eliminates geographic variation in
risk factors as a confounder, but where expo-
sure variation comes from temporal changes in
pollution concentration; and b) by focusing on
associations on an intermediate time scale. If
PM increases progression of atherosclerosis
(Künzli et al. 2005; Suwa et al. 2002) or
impairs endothelial function (Brook et al.
2004) or autonomic function (Liao et al. 1999;
O’Neill et al. 2005), these changes may have
greater impact in populations with greater
underlying impairment, such as the elderly. 
A primary candidate for explaining these
risks must be the acute MI itself (Berger et al.
1992; Guidry et al. 1999; Kannel et al. 1979).
Subjects surviving MIs have enhanced risk of
dying and decreased heart rate variability
(Malik et al. 1989), and are likely to have
greater susceptibility to subsequent insults. 
This possibility of multiple pathways to
mortality makes it plausible that the all-cause
mortality risk might exceed the risk of speciﬁc
cardiac events, as we observe for subsequent
MI. For example, PM has been associated
with arrhythmias (Peters et al. 2000), pneu-
monia (Zanobetti et al. 2000), and COPD
(Schwartz 1993), creating potential additional
pathways by which exposure could increase
mortality risk independent of MI risk. 
One limitation of the present study is that
Medicare does not provide the underlying
cause of death. If the cause of death were
available, we could understand better the
possible pathways. 
Future studies examining cohorts with
more detailed clinical data on the MI survivors
should be fruitful. The increased risk of heart
failure following the MI also suggests that fur-
ther evaluation of this outcome is warranted. 
The present study presents additional lim-
itations, the main one being the absence of
information on subject characteristics such as
smoking, body mass index, or medicine use,
and information on whether the patients
migrated out of the study areas after their last
Medicare contact. However, we were able to
adjust for other important characteristics such
as age, race, sex, the type of MI, and previous
and secondary diagnoses. Missing those other
characteristics would only confound the
association with air pollution if they were
correlated with pollution. However, we con-
ducted a city-speciﬁc analysis to remove loca-
tion-speciﬁc differences in the analyses. Hence,
differences across cities in smoking rates, for
example, cannot confound the association,
because only the temporal variability in
Table 7. Modiﬁcation of the PM10 association in the three survival analyses by city characteristics across
21 U.S. cities expressed as HR and 95% CI for 10-µg/m3 increase in PM10 (distributed lag) estimated at the
25th percentile and the 75th percentile of the effect modiﬁer.
City  p-Value HR at the 25% percentile HR at the 75% percentile
characteristic for modiﬁer 1st quartile HR 95% CI 3rd quartile HR 95% CI
Population ≥ 65 years of age in poverty status (%)
Death 0.60 8.0 1.34 1.06–1.70 11.4 1.27 1.05–1.53
CHF 0.83 1.36 1.05–1.75 1.32 1.08–1.62
MI 0.61 1.29 0.91–1.82 1.19 0.91–1.56
Annual mortality rate for emphysema ≥ 65 years of age
Death 0.57 32.9 1.33 1.07–1.67 47.6 1.27 1.04–1.54
CHF 0.37 1.42 1.12–1.79 1.30 1.06–1.60
MI 0.97 1.26 0.91–1.73 1.25 0.94–1.66
Mean PM10
Death 0.60 25.5 1.25 1.01–1.55 32.1 1.33 1.07–1.65
CHF 0.74 1.36 1.08–1.72 1.30 1.03–1.64
MI 0.04 1.02 0.76–1.37 1.43 1.08–1.91
IQR PM10
Death 0.70 3.3 1.31 1.07–1.62 5.5 1.26 1.02–1.56
CHF 0.38 1.40 1.12–1.74 1.26 1.01–1.58
MI 0.28 1.12 0.83–1.50 1.33 0.98–1.79
Population density
Death 0.67 594.8 1.33 1.06–1.67 2076.9 1.27 1.05–1.54
CHF 0.75 1.30 1.02–1.66 1.35 1.10–1.65
MI 0.74 1.17 0.84–1.64 1.23 0.93–1.62
IQR, interquartile range. 
Figure 1. Effect modification by sex and age group in the three survival analyses, in which failure
is defined as death, a subsequent MI, or CHF. The effects were computed by stratified analysis for
each sex or age group (65–75 years or > 75 years) and PM10 averaged over 3 years. Effects are computed
for 10 µg/m3 PM10.
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ation. Smoking could only confound this asso-
ciation if year-to-year variations in smoking
rates within city covaried with year-to-year
variations in PM10 concentrations. Moreover,
we examined the emphysema death rate in
persons > 65 years of age as an effect modiﬁer
because it is associated with smoking history
in the population, and found that it did not
modify the PM-associated risk. Thus, smoking
is unlikely to be a confounder in our study. 
Our findings that both subsequent MIs
and CHF admissions, as well as mortality
risk, are elevated suggests that multiple path-
ways are involved in the particle effects. 
Other human and animal studies (Godleski
et al. 2000) have shown associations between
particulate pollution and changes in heart rate
variability (Gold et al. 2000; Liao et al. 1999;
Pope et al. 1999); increases in plasma viscosity
(Peters et al. 1997), C-reactive protein (Brook
et al. 2003; Peters et al. 2001b; Pope et al.
2004b), plasma ﬁbrinogen (Ghio et al. 2000),
white blood cell counts (Salvi et al. 1999;
Schwartz 2001), blood pressure (Ibald-Mulli
et al. 2001; Linn et al. 1999; Zanobetti et al.
2004), and oxidative stress (Bouthillier et al.
1998; Brook et al. 2003; Sorensen et al. 2003);
decreases in plaque stability (Suwa et al. 2002);
or occurrence of thrombotic complications after
exposure to pollutants (Nemmar et al. 2003).
In a recent study O’Neill et al. (2005) reported
that PM was associated with flow-mediated
dilation of the brachial arteries. 
Many of these associations are with acute
exposure, not long-term exposures such as
those used in the present study. Nevertheless,
the associations suggest that the hypotheses to
explain the potential mechanisms for the par-
ticle effects might involve systemic inﬂamma-
tion, changes in autonomic function, or
oxidative stress capable of influencing both
cardiovascular and pulmonary physiology. 
Our ﬁndings suggest that persons surviving
an MI are at risk from exposure to particulate
pollution. This is a large group, and hence this
ﬁnding has substantial public health implica-
tions. Our results also suggest that it would be
beneficial to examine this population in
mechanistic studies. 
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